SEARCH

SEARCH BY CITATION

References

  • 1
    Gershon RK, Eardley DD, Derum S, Green DR, Shen FW, Yamauchi K, Cantor H, Murphy DB. Contrasuppression: a novel immunoregulatory activity. J Exp Med 1981; 153:153346.
  • 2
    Cantor H, Boyse EA. Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol 1977; 41:2332.
  • 3
    Cantor H, Gershon RK. Immunological circuits: cellular composition. Fed Proc 1979; 38:205864.
  • 4
    Eardley DD, Murphy DB, Kemp JD, Shen FW, Cantor H, Gershon RK. Ly-1 inducer and Ly-1, 2 acceptor T cells in the feedback suppression circuit bear an I–J subregion controlled determinant. Immunogenetics 1980; 11:54957.
  • 5
    Green DR, Eardley DD, Kimura A, Murphy DB, Yamauchi K, Gershon RK. Immunoregulatory circuits which modulate responsiveness to suppressor signals: characterization of an effector cell in the contrasuppressor circuit. Eur J Immunol 1981; 11:97380.
  • 6
    Paliwal V, Freidman AM, Ptak W, Askenase PW. Monoclonal, antigen-specific, T cell contrasuppressor factor expresses determinants of TCR a-chain (not necessarily TCR β-chain), having a molecular mass of about 40 kDa. J Immunol 1994; 152:281120.
  • 7
    Yamauchi KD, Murphy H, Cantor H, Gershon RK. Analysis of an antigen-specific H-2-restricted cell-free product(s) made by ‘I–J–’ Ly-2 cells (Ly-2 TsF) that suppresses Ly-2 cell-depleted spleen cell activity. Eur J Immunol 1981; 11:9138.
  • 8
    Braley-Mullen H. Characterization and activity of contrasuppressor T cells induced by type III pneumococcal polysaccharide. J Immunol 1986; 137:27617.
  • 9
    Smith HRD, Green DR, Smathers PA, Gershon RK, Raveche ES, Steinberg AD. Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin Exp Immunol 1983; 51:57986.
  • 10
    Suzuki I, Kiyono H, Kitamura K, Green DR, McGhee JR. Abrogation of oral tolerance by contrasuppressor T cells suggests the presence of regulatory T cell networks in the mucosal immune system. Nature 1986; 320:4514.
  • 11
    Flood PM, Freidman A, Freedman J, Horvat B, Reuter P, Ptak W. The role of contrasuppressor in tumor regression. Immunol Res 1988; 7:1222.
  • 12
    Ptak W, Bereta M, Marcinkiewicz J, Gershon RK, Green DR. Production of antigen-specific contrasuppressor cells and factor, and their use in augmentation of cell-mediated immunity. J Immunol 1984; 133:6238.
  • 13
    Friedman AM, Ptak E, Brewer E, Green DR, Reuter PA, Flood PM. Generation of a T cell hybridoma producing a contrasuppressor factor for contact sensitivity. Immunology 1990; 71:2829.
  • 14
    Ptak W, Bereta M, Ptak M, Gershon R, Green DR. Antigen-specific T contrasuppressor factor in cell-mediated immunity: interaction leading to eradication of the tolerant state. J Immunol 1984; 133:112430.
  • 15
    Kimura A, Wigzell H, Holmquist G, Ersson B, Carsson P. Selective affinity fractionation of murine cytotoxic T lymphocytes (CTL). J Exp Med 1979; 149:47384.
  • 16
    Lehner T. The relationship between human helper and suppressor factors to a streptococcal protein antigen. J Immunol 1982; 129:193640.
  • 17
    Lehner T, Lamb JR, Kontiainen S. Cell-bound helper and suppressor factors in primate lymphocytes. Clin Exp Immunol 1982; 47:70614.
  • 18
    Lehner T, Brines R, Jones T, Avery J. Detection of cross-reacting murine I–J like determinants on a human subset of T8+ antigen binding, presenting and contrasuppressor cells. Clin Exp Immunol 1984; 58:4109.
  • 19
    Brines R, Lehner T. Antigen presentation by a subset of T8+ Ia+ cells to T4+ helper cells. Clin Exp Immunol 1987; 67:398405.
  • 20
    Fortune F, Lehner T. Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus. Clin Exp Immunol 1988; 74:1004.
  • 21
    Fortune F, Kingston J, Barnes C, Lehner T. Identification and characterisation of IgA and Vicia villosa-binding T cell subsets in rheumatoid arthritis. Clin Exp Immunol 1990; 79:2028.
  • 22
    Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6:34552.
  • 23
    Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007; 8:45762.
  • 24
    Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6:35360.
  • 25
    Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+ CD25+ cells educate CD4+ CD25 cells to develop suppressive activity: the role of IL-2, TGF-γ, and IL-10. J Immunol 2004; 172:521321.
  • 26
    Chen W, Jen W, Hardegen N, Lei K, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+ CD25 naive T cells to CD4+ CD25+ regulatory T cells by TGF-β induction of transcription factor FoxP3. J Exp Med 2003; 198:187586.
  • 27
    Griffith TS, Kazama H, VanOosten RL, Earle JK, Herndon JM, Green DR, Ferguson TA. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 2007; 178:267987.
  • 28
    Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971; 21:90314.
  • 29
    Greene MI, Benacerraf B. Studies on hapten specific T cell immunity and suppression. Immunol Rev 1980; 50:16386.
  • 30
    Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:2358.
  • 31
    Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+ CD25+ regulatory T cells. Semin Immunol 2004; 16:8997.
  • 32
    Griffin MD, Hong DK, Holman PO et al. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J Immunol 2000; 164:443342.
  • 33
    Khoury SJ, Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004; 20:52938.
  • 34
    Stephens GL, McHugh S, Whitters MJ, Young DA, Luxenberg D, Carreno BM, Collins M, Shevach EM. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells. J Immunol 2004; 173:500820.
  • 35
    Shevach EM, Stephens GL. The GITR–GITRL interaction: co-stimulation of contrasuppression of regulatory activity? Nat Rev Immunol 2006; 6:6138.
  • 36
    Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+ CD25+ TR cells cuppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197:1119.
  • 37
    Agata Y, Kawaskai A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8:76572.
  • 38
    Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-γ-induced nitric oxide production. J Immunol 2002; 175:158692.
  • 39
    Freeman GJ, Wherry EF, Ahmed R, Sharpe AH. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blocks. J Exp Med 2006; 203:22237.
  • 40
    Latchman Y et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2:2618.
  • 41
    Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11:14151.
  • 42
    Carter LL, Fouser LA, Jussif J et al. PD-1: PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2. Eur J Immunol 2002; 32:63443.
  • 43
    Trautmann L, Janbazian L, Chomont N et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198202.
  • 44
    Petrovas C, Casazza JP, Brenchley JM et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203:228192.
  • 45
    Day CL, Kaufmann DE, Kiepiela P et al. PD-1 expression on HIV-specific T cells associated with T-cell exhaustion and disease progression. Nature 2006; 443:3504.
  • 46
    Kitazawa Y, Fujino Q, Wang Q, Kimura H, Azuma M, Kubo M, Abe R, Li X-K. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune response. Transplantation 2007; 83:77482.
  • 47
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299:10336.
  • 48
    Liu H, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signalling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2006; 103:704853.
  • 49
    Peng G, Guo Z, Kiniwa Y et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005; 309:13804.
  • 50
    Sutmuller RPM, Morgan ME, Netea MG, Grauer O, Adema GJ. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 2006; 27:38793.